Internal Medicine, Hematology & Oncology · Birmingham, AL
NPI
1598965972
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1717 6th Ave S
Birmingham, AL, 35233
Phone (800) 822-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
293 services
Medicare patients, 2024
60
Average age 69
Drug cost, 2024
$3.4M
833 prescriptions
Company payments, 2025
$5,997
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gabrielle Rocque was code 99215 (office e&m - established), 110 times for 35 patients. In total Gabrielle Rocque billed 293 services in 7 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 110 | 35 | $98.27 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 110 | 39 | $11.85 | $1,304 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Facility | 42 | 15 | $70.70 | $2,969 |
| 99214 Office E&M - Established | Facility | 17 | 16 | $66.78 | $1,135 |
By year: 2022 $17K for 167 services; 2023 $15K for 155 services; 2024 $17K for 293 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gabrielle Rocque prescribed most often to Medicare patients was Ibrance (Palbociclib), with 123 prescriptions and refills. In total Gabrielle Rocque wrote 833 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ibrance Palbociclib | 123 | 126 | 16 | $1.9M |
| Letrozole Generic | 86 | 173 | 27 | $1,458 |
| Gabapentin Generic | 38 | 50 | 13 | $460 |
| Oxycodone Hcl Generic | 33 | 33 | Under 11 | $1,092 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 30 | 31 | Under 11 | $791 |
| Morphine Sulfate Er Morphine Sulfate | 30 | 30 | Under 11 | $996 |
| Ondansetron Hcl Generic | 28 | 29 | 21 | $666 |
| Eliquis Apixaban | 22 | 28 | Under 11 | $16K |
| Duloxetine Hcl Generic | 22 | 38 | Under 11 | $508 |
| Trazodone Hcl Generic | 19 | 31 | Under 11 | $110 |
| Kisqali Ribociclib Succinate | 18 | 18 | Under 11 | $244K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 18 | 26 | Under 11 | $223 |
| Oxycontin Oxycodone Hcl | 16 | 16 | Under 11 | $8,851 |
| Anastrozole Generic | 15 | 37 | Under 11 | $361 |
| Orserdu Elacestrant Hcl | 15 | 15 | Under 11 | $316K |
Brand drugs: - claims; generic drugs: 537 claims; opioid claims: 144.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gabrielle Rocque $5,997 ($5,997 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $3,088.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.